Doctor profile · Federal record
Dr. LEAH WALSH, FNP-BC
Nurse Practitioner · SOUTH LAKE TAHOE, CA
- NPI 1922643386
- Accepts Medicare
- MIPS 91.1 / 100 · 2023
- 7 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2170B SOUTH AVE
SOUTH LAKE TAHOE, CA 961507026
(530) 539-6620 - Mailing address
-
1385 VISTA LN
CARSON CITY, NV 897034643
Credentials & registration
- NPI registered
- November 2019 — 7 yrs on file
- Profile last updated
- October 26, 2021
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Nevada #825862
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1922643386. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,327
Distinct HCPCS
8
Medicare allowed
$241,535
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 7,620 | 74 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 394 | 261 | $114 | |
96372 |
Injection of drug or substance under skin or into muscle | 134 | 76 | $13 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 63 | 61 | $82 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 42 | 42 | $150 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 28 | 28 | $101 | |
99442 |
Telephone medical discussion with physician, 11-20 minutes | 25 | 21 | $59 | |
99443 |
Telephone medical discussion with physician, 21-30 minutes | 21 | 20 | $88 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 373. This provider delivers 22× the peer median.Open Payments
Industry payments received
All-time total
$182
Transactions
10
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $58.09 | |
| ABBVIE INC. | 2 | $35.61 | |
| Janssen Biotech, Inc. | 1 | $28.49 | |
| PFIZER INC. | 1 | $18.55 | |
| GlaxoSmithKline, LLC. | 1 | $14.42 | |
| Kiniksa Pharmaceuticals International, plc | 1 | $13.80 | |
| Evolution Surgical, Inc | 1 | $13.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
687
Patients
199
Total drug cost
$1,327,549
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 94 | 47 | $4,631 |
| Alendronate Sodium | Generic | 81 | 30 | $1,598 |
| Prednisone | Generic | 75 | 41 | $811 |
| Leflunomide | Generic | 72 | 35 | $4,730 |
| Hydroxychloroquine Sulfate | Generic | 57 | 28 | $5,700 |
| Enbrel Sureclick (Etanercept) | Brand | 46 | 0 | $363,455 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 39 | 18 | $2,152 |
| Humira(Cf) Pen (Adalimumab) | Brand | 37 | 0 | $296,753 |
| Tymlos (Abaloparatide) | Brand | 37 | 0 | $103,414 |
| Allopurinol | Generic | 33 | 0 | $578 |